Protara Therapeutics, Inc. (TARA) stock
TARANasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
$2.32−0.06 (-2.52%)
Close on Nov 17, 2026Market cap $137.10MP/E –Yield –
Protara Therapeutics operating margin
Operating margin is operating income as a percentage of revenue.
For fiscal 2014 it was -257.1%.
Annual operating margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2014 | Dec 31, 2014 | -257.1% | – |
See a number that looks wrong?